Effect of preoperative transcatheter arterial chemoembolization on proliferation of hepatocellular carcinoma cells

World Journal of Gastroenterology

Volumn 13, Issue 33, 2007, Pages 4509-4513

  Xiao, En Hua ^a   Li, Jing Qing ^b   Huang, Jie Fu ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Ki 67; Proliferating cell nuclear antigen; Transcatheter arterial chemoembolization

Indexed keywords

ALCOHOL; CARBOPLATIN; CYCLINE; EPIRUBICIN; FLUOROURACIL; GELATIN SPONGE; IODINATED POPPYSEED OIL; KI 67 ANTIGEN; MITOMYCIN C;

ADULT; AGED; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL PROLIFERATION; CHEMOEMBOLIZATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MIXTURE; ECHOGRAPHY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MITOSIS INHIBITION; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NONHUMAN; PREOPERATIVE TREATMENT; PROTEIN EXPRESSION;

EID: 34548696626     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i33.4509     Document Type: Article

References (22)

1. Cai J, Hu J, Che X, Zhao J, Bi X, Shao Y. Prognosis of primary liver carcinoma treated with local resection. Chin Med J (Engl) 2003; 116: 187-190
2. Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M. Transcatheter arterial chemoembolization therapy using iodized off for patients with urtresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 2000; 88: 1574-1581
3. Perry A, Jenkins RB, O'Fallon JR, Schaefer PL, Kimmel DW, Mahoney MR, Scheithauer BW, Smith SM, Hill EM, Sebo TJ, Levitt R, Krook J, Tschetter LK, Morton RF, Buckner JC. Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression. Cancer 1999; 86: 672-683
4. Xiao EH, Li JQ, Huang JF. Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization. World J Gastroenterol 2004; 10: 190-194
5. Rose DM, Chapman WC, Brockenbrough AT, Wright JK, Rose AT, Meranze S, Mazer M, Blair T, Blanke CD, Debelak JP, Pinson CW. Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg 1999; 177: 405-410
6. Igarashi N, Takahashi M, Ohkubo H, Omata K, Iida R, Fujimoto S. Predictive value of Ki-67, p53 protein, and DNA content in the diagnosis of gastric carcinoma. Cancer 1999; 86: 1449-1454
7. Fukuse T, Hirata T, Naiki H, Hitomi S, Wada H. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases. Cancer 1999; 86: 1174-1181
8. Kitamoto M, Nakanishi T, Kira S, Kawaguchi M, Nakashio R, Suemori S, Kajiyama G, Asahara T, Dohi K. The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis. Cancer 1993; 72: 1859-1865
9. Li JQ, Zhang CQ, Zhang YQ. Immunohistochemical study of PCNA and p53 in primary liver cancer: An implication for prognosis and treatment. J Exp Clin Cancer Res 1996; 15: 77-82
10. Xiao EH, HU GD, Li JQ, Zhang YQ, Chen MS. The effect of different chemoembolization methods on PI, SPF and DI in different histopathological types of hepatocellular carcinoma. Linchuang Fangshexue Zazhi 2001; 20: 624-627
11. Huang J, He X, Lin X, Zhang C, Li J. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma. Chin Med J (Engl) 2000; 113: 446-448
12. Xiao EH, Hu GD, Li JQ, Zhang YQ, Chen MS, Guo YP, Lin XJ, Li SP, Li GH. The relationship between the tumor necrosis and transcatheter arterial chemoembolization methods for hepatocellular carcinoma. Linchuang Fangshexue Zazhi 2000; 19: 513-515
13. Hsu HC, Sheu JC, Lin YH, Chen DS, Lee CS, Hwang LY, Beasley RP. Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCC. Cancer 1985; 56: 672-680
14. Zhu ZG, Cuo BH. Analyhuosis of efficacy of resection of liver cancer after transhepatic artery chemoembolization. Gandanyi Waike Zazhi 1997; 9: 158-159
15. Liang LJ, Lin HL, Huang JF. The clinical and pathological features of resected hepatocellular carcinoma after hepatic arterial chemoembolization. Aizheng Zazhi 1993; 12: 148-150
16. Lai RQ, Hao CZ, Wang JX. Pathomorphological study of resected hepatocellular carcinoma after transcatheter hepatic arterial chemoembolization. Zhonghua Binglixue Zazhi 1993; 22: 19-21
17. Zhang BH, Quan GX, Wu MC. Selection of surgical time for resectableliver cancer after transcatheter hepatic artery embolization. Gandanyi Waike Zazhi 1997; 9: 153-155
18. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer 1991; 68: 2150-2154
19. Teng GJ, He SC, Guo JH. Resection of hepatocellular carcinoma folloeing transcatheter hepatic artery embolization. Zhonghua Fangshexue Zazhi 1994; 28: 597-600
20. Spreafico C, Marchiano A, Regalia E, Frigerio LF, Garbagnati F, Andreola S, Milella M, Lanocita R, Mazzaferro V. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 1994; 192: 687-690
21. Zhang ZJ, Wu MC, Liu Q. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Zhonghua Zhongliu Zazhi 1999; 21: 214-216
22. Xiao EH, Hu GD, Li JQ, Zhang YQ, Chen MS, Guo YP, Lin XJ, Li SP, Li GH. The relationship between the tumor tissue reaction and transcatheter arterial chemoembolization methods for hepatocellular carcinoma. Shiyong Fangshexue Zazhi 2001; 17: 324-326